painreform.com (PRFX): Rega marang bathi kanthi panyesuaian wutah
The development of PainReform Ltd. (PRFX) depends on regulatory approval and the recognition of the effectiveness of new pain management systems by surgeons. A key advantage of PRF-110 is its oil-based composition, which provides pain blockage for 72 hours, ensuring strong pricing power. The peg_co ratio confirms this potential, with the value stabilizing at 0.00. Currently, the company is burning capital while awaiting the completion of tests to create market momentum.
Rincian metrik lan analitis perusahaan PainReform Ltd. (PRFX)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- data nilai buku modal saham:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal PainReform Ltd.|PRFX - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal painreform.com|PRFX - Utang perusahaan|Rasio utang-utang marang kapitalisasi buku PainReform Limited|PRFX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan PainReform|Koefisien jangkoan perantara painreform.com
- statistik bathi lan rasio pasar:
PRFX - Bathi resik perusahaan|Prakiraan bathi resik PainReform Ltd.|PRFX - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi PainReform Corp|PRFX - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan PainReform Limited|PRFX - Bathi operasional EBITDA|Bathi saben siji saham sajrone 12 wulan pungkasan PainReform|PRFX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan painreform.com|PRFX - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep PainReform Ltd.
Analisis fundamental perusahaan:PainReform Ltd - PRFX
This indicator compares the market value of the stock with net profit dynamics to determine the investment efficiency per one percent of business growth. By analyzing the P/E ratio relative to earnings growth rates, an investor can assess the undervaluation of PainReform Ltd. (PRFX), considering the low demand elasticity for the unique drug PRF-110, which confirms the issuer's potential pricing power over the long term.
Perusahaan pesaing
HLN (Haleon PLC) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Kenvue Corp KVUE|Verona Pharma Inc. (VRNA) - Rega marang bathi kanthi panyesuaian wutah|MENS: Pangali rega marang bathi tumrap wutah|ligand.com - Rasio nilai perusahaan marang wutah bathi|AMRX: Pangali PEG|Perrigo Company PLC - Koefisien bali modal nimbang wutah|ALVO (Alvotech Corp) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Liquidia Inc. LQDA|Rasio rega marang bathi tumrap wutah Galapagos NV (GLPG)|ANIP (anipharmaceuticals.com) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah MannKind MNKD|AMPH (Amphastar Pharmaceuticals Inc) - Rasio kapitalisasi marang bathi lan wutah|Pacira - Pangali PEG|SPRY - Pangali PEG|TBPH: Pangali PEG|AQST - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah scPharmaceuticals, Inc.|Rasio P/E diaturake wutah TECX (Tectonic)|Rasio rega marang bathi tumrap wutah Tonix Pharmaceuticals Inc. (TNXP)|SXTC (sxtchina.com) - Koefisien bali modal nimbang wutah|Pangali PEG EPRX (Eupraxia Pharmaceuticals Inc.)|bioharvest.com (BHST) - Rega marang bathi kanthi panyesuaian wutah|eXoZymes - Pangali PEG|Rasio kapitalisasi marang bathi lan wutah ORMP|enterabio.com (ENTX) - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah MindWalk Therapeutics (HYFT)|Rasio rega marang bathi tumrap wutah ABVC BioPharma|CPIX: Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Quantum BioPharma (QNTM)|Pangali rega marang bathi tumrap wutah FibroGen Inc FGEN|Telomir Pharma - Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah RANI|SNYR - Rasio rega marang bathi tumrap wutah|RLYB: Rasio rega marang bathi tumrap wutah|LEXX (lexariabioscience.com) - Pangali rega marang bathi tumrap wutah|PULM: Rasio nilai perusahaan marang wutah bathi|PTHL (Pheton Holdings Limited) - Pangali PEG|Rasio P/E diaturake wutah APM (Aptorum)|Pangali rega marang bathi tumrap wutah LYRA (Lyra Therapeutics, Inc.)|Kapitalisasi marang bathi resik kanthi nimbang wutah impactbiomedinc.com|Rasio rega marang bathi tumrap wutah TNF Pharmaceuticals, Inc. TNFA|YCBD (cbdMD Inc.) - Rasio kapitalisasi marang bathi lan wutah|CYTO - Rasio rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah LIPO (Lipella Pharma)|OPTN: Pangali PEG|Rasio kapitalisasi marang bathi lan wutah PIRS (pieris.com)|Pangali rega marang bathi tumrap wutah PROC|Rasio P/E diaturake wutah PTPI (Petros Pharmaceuticals Inc)|Rasio rega marang bathi tumrap wutah Qilian International Holding Group Limited (QLI)|SLRN: Rasio kapitalisasi marang bathi lan wutah|Pangali PEG TFFP (TFF Pharmaceuticals)
